NEW YORK--(BUSINESS WIRE)--Pluristem Therapeutics Inc. (Nasdaq:PSTI)(DAX:PJT), a bio-therapeutics company dedicated to the commercialization of non-personalized (allogeneic) cell therapy products for a variety of degenerative, ischemic and autoimmune indications, announced today that Zami Aberman, President & CEO of the Company, will present at the bioLOGIC Europe 2008 conference on Tuesday, September 16, 2008 at 11:15 a.m. Central European Time at the Crowne Plaza Hotel, Geneva, Switzerland.
